Inflammatory Cardiomyopathy: A Current View on the
Pathophysiology, Diagnosis, and Treatment

J 2016

Inflammatory Cardiomyopathy: A Current View on the Pathophysiology, Diagnosis, and Treatment

KREJČÍ, Jan, Dalibor MLEJNEK, Dana SOCHOROVÁ a Petr NĚMEC

Základní údaje

Originální název

Inflammatory Cardiomyopathy: A Current View on the Pathophysiology, Diagnosis, and Treatment

Autoři

KREJČÍ, Jan (203 Česká republika, domácí), Dalibor MLEJNEK (203 Česká republika, domácí), Dana SOCHOROVÁ (203 Česká republika, domácí) a Petr NĚMEC (203 Česká republika, garant, domácí)

Vydání

Biomed Research International, New York, Hindawi Publishing Corporation, 2016, 2314-6133

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 2.476

Kód RIV

RIV/00216224:14110/16:00090788

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1155/2016/4087632

UT WoS

000378704900001

Klíčová slova anglicky

GIANT-CELL MYOCARDITIS; CARDIOVASCULAR MAGNETIC-RESONANCE; VENTRICULAR ENDOMYOCARDIAL BIOPSY; ACUTE VIRAL MYOCARDITIS; ONSET DILATED CARDIOMYOPATHY; HEART-FAILURE ASSOCIATION

Štítky

EL OK

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 12. 9. 2016 13:01, Ing. Mgr. Věra Pospíšilíková

Anotace

V originále

Inflammatory cardiomyopathy is defined as inflammation of the heart muscle associated with impaired function of the myocardium. In our region, its etiology is most often viral. Viral infection is a possible trigger of immune and autoimmune mechanisms which contributed to the damage of myocardial function. Myocarditis is considered the most common cause of dilated cardiomyopathy. Typical manifestation of this disease is heart failure, chest pain, or arrhythmias. The most important noninvasive diagnostic method is magnetic resonance imaging, but the gold standard of diagnostics is invasive examination, endomyocardial biopsy. In a significant proportion of cases with impaired left ventricular systolic function, recovery occurs spontaneously in several weeks and therefore it is appropriate to postpone critical therapeutic decisions about 3-6 months after start of the treatment. Therapy is based on standard heart failure treatment; immunosuppressive or antimicrobial treatment may be considered in some cases depending on the results of endomyocardial biopsy. If severe dysfunction of the left ventricle persists, device therapy may be needed.

Citovat

KREJČÍ, Jan, Dalibor MLEJNEK, Dana SOCHOROVÁ a Petr NĚMEC. Inflammatory Cardiomyopathy: A Current View on the Pathophysiology, Diagnosis, and Treatment. Biomed Research International. New York: Hindawi Publishing Corporation, 2016, roč. 2016, č. 4087632, s. 1-11. ISSN 2314-6133. Dostupné z: https://dx.doi.org/10.1155/2016/4087632.

@article{1353913,
   author = {Krejčí, Jan and Mlejnek, Dalibor and Sochorová, Dana and Němec, Petr},
   article_location = {New York},
   article_number = {4087632},
   doi = {http://dx.doi.org/10.1155/2016/4087632},
   keywords = {GIANT-CELL MYOCARDITIS; CARDIOVASCULAR MAGNETIC-RESONANCE; VENTRICULAR ENDOMYOCARDIAL BIOPSY; ACUTE VIRAL MYOCARDITIS; ONSET DILATED CARDIOMYOPATHY; HEART-FAILURE ASSOCIATION},
   language = {eng},
   issn = {2314-6133},
   journal = {Biomed Research International},
   title = {Inflammatory Cardiomyopathy: A Current View on the Pathophysiology, Diagnosis, and Treatment},
   volume = {2016},
   year = {2016}
}

TY  - JOUR
ID  - 1353913
AU  - Krejčí, Jan - Mlejnek, Dalibor - Sochorová, Dana - Němec, Petr
PY  - 2016
TI  - Inflammatory Cardiomyopathy: A Current View on the Pathophysiology, Diagnosis, and Treatment
JF  - Biomed Research International
VL  - 2016
IS  - 4087632
SP  - 1-11
EP  - 1-11
PB  - Hindawi Publishing Corporation
SN  - 23146133
KW  - GIANT-CELL MYOCARDITIS
KW  - CARDIOVASCULAR MAGNETIC-RESONANCE
KW  - VENTRICULAR ENDOMYOCARDIAL BIOPSY
KW  - ACUTE VIRAL MYOCARDITIS
KW  - ONSET DILATED CARDIOMYOPATHY
KW  - HEART-FAILURE ASSOCIATION
N2  - Inflammatory cardiomyopathy is defined as inflammation of the heart muscle associated with impaired function of the myocardium. In our region, its etiology is most often viral. Viral infection is a possible trigger of immune and autoimmune mechanisms which contributed to the damage of myocardial function. Myocarditis is considered the most common cause of dilated cardiomyopathy. Typical manifestation of this disease is heart failure, chest pain, or arrhythmias. The most important noninvasive diagnostic method is magnetic resonance imaging, but the gold standard of diagnostics is invasive examination, endomyocardial biopsy. In a significant proportion of cases with impaired left ventricular systolic function, recovery occurs spontaneously in several weeks and therefore it is appropriate to postpone critical therapeutic decisions about 3-6 months after start of the treatment. Therapy is based on standard heart failure treatment; immunosuppressive or antimicrobial treatment may be considered in some cases depending on the results of endomyocardial biopsy. If severe dysfunction of the left ventricle persists, device therapy may be needed.
ER  -

KREJČÍ, Jan, Dalibor MLEJNEK, Dana SOCHOROVÁ a Petr NĚMEC. Inflammatory Cardiomyopathy: A Current View on the Pathophysiology, Diagnosis, and Treatment. \textit{Biomed Research International}. New York: Hindawi Publishing Corporation, 2016, roč.~2016, č.~4087632, s.~1-11. ISSN~2314-6133. Dostupné z: https://dx.doi.org/10.1155/2016/4087632.

Podrobný výpis o publikaci